Evidence map›Paper›PMID 41218838›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2025

Predicting drug overdose and death after "before medically advised" hospital discharge.

Hiten Naik, Daniel Daly-Grafstein, Xiao Hu, Mayesha Khan, Benjamin M Kaasa, Jeffrey R Brubacher, Trudy Nasmith, Jennifer R Lyden, Jessica Moe, Alexis Crabtree and 2 more

Abstract read
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hiten NaikDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC. hiten.naik@ubc.ca.
Daniel Daly-GrafsteinDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC.
Xiao HuDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC.
Mayesha KhanDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC.
Benjamin M KaasaDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC.
Jeffrey R BrubacherDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC.
Trudy NasmithDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC.
Jennifer R LydenDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC.
Jessica MoeDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC.
Alexis CrabtreeDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC.
Amanda K SlaunwhiteDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC.
John A StaplesDepartments of Medicine (Naik, Daly-Grafstein, Hu, Khan, Nasmith, Staples), Statistics (Daly-Grafstein, Hu), Emergency Medicine (Brubacher, Moe), Pathology, and Laboratory Medicine (Slaunwhite), University of British Columbia, Vancouver, BC; Department of Family and Community Medicine (Kaasa), University of Toronto, Toronto, Ont.; Department of Internal Medicine (Lyden), Denver Health, Denver, Colo.; Department of Internal Medicine (Lyden), University of Colorado School of Medicine, Aurora, Colo.; British Columbia Centre for Disease Control (Moe, Crabtree); School of Population and Public Health (Crabtree, Slaunwhite), University of British Columbia; British Columbia Centre on Substance Use (Crabtree); BC Mental Health and Substance Use Services (Slaunwhite), Provincial Health Services Authority; Centre for Clinical Epidemiology & Evaluation (Staples), Vancouver, BC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background"Before medically advised" (BMA) hospital discharge is associated with higher risks for subsequent death and drug overdose. We sought to develop prediction models to estimate the absolute risk of death from any cause and illicit drug overdose after BMA discharge for a given patient.

methodsWe used retrospective population-based administrative health data of a 20% random sample of all British Columbia residents to derive and internally validate regression models to estimate the risks of death (model A) and illicit drug overdose (model B) within 30 days after BMA discharge. Model A included all nonelective, nonobstetrical adult hospitalizations ending in BMA discharge between 2015 and 2019. Model B included only hospitalizations from model A for patients with evidence of prior substance use. We fitted prediction models using logistic regression and validated models using bootstrap-based optimism correction. Candidate predictors included sociodemographic and clinical characteristics available to clinicians during BMA discharge.

resultsOf 6440 hospital admissions included in model A, 102 (1.6%) were associated with the death of a patient within 30 days of BMA discharge. Predictors for death included a Charlson Comorbidity Index of 2 or higher, cancer, and heart disease. Model A exhibited good discrimination (C-statistic = 0.78) and excellent calibration. Of 4466 hospital admissions included in model B, 233 (5.2%) were associated with a patient subsequently overdosing within 30 days of BMA discharge. Predictors for drug overdose included homelessness, receipt of social income assistance, opioid use disorder, non-alcohol substance use disorder, overdose in the past year, and discharge from a surgical service. Model B exhibited good discrimination (C-statistic = 0.79) and excellent calibration.

interpretationRisk prediction models may help clinicians and hospitals identify patients who might benefit from intensive support to prevent death or illict drug overdose after BMA discharge.

Indexed as

Drug OverdosePatient DischargeAdultAgedBritish ColumbiaFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsSubstance-Related Disorders

Identifiers

PMID41218838
PMCPMC12594543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.